Skip to content
Screener

Lantheus Holdings LNTH Operating Cash Flow

Operating Cash Flow at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$168M+78.7%
Immunome logo
ImmunomeIMNM
-$58.64M-10.5%
Perspective Therapeutics logo
Perspective TherapeuticsCATX
-$31.47M-45.8%
RadNet logo
RadNetRDNT
$78.97M+90.4%
BillionToOne, Inc. logo
BillionToOne, Inc.BLLN
$9.14M+673%
CTO
Citius Oncology, Inc.CTOR
-$3.83M-179%

Other financials

Income statement

See full
Revenue$388.2M+2.7%
Gross profit$241.9M+0.4%
Operating income$100.2M+13.9%
Net income$75.0M-4.7%
EPS (diluted)$1.11-0.9%

Balance sheet

See full
Cash & equivalents$595.0M-14.7%
Total debt$626.8M+1.5%
Total equity$1.3B+12.4%
Total assets$2.4B+14.1%

Cash flow

See full
CapEx$2.3M-70.7%
Free cash flow$89.9M+13.5%

Valuation

See full
Market cap$6.63B+84.6%
Enterprise value$6.66B+89.7%
P/E24.1×+11.4×
P/S4.3×+1.9×

Profitability

See full
Gross margin60.1%-3.6pp
Operating margin19.4%-9.4pp
Net margin17.7%-0.9pp
FCF margin24.9%-6.6pp

Returns & leverage

See full
Return on equity22.2%-3.6pp
Debt / equity0.5×-0.1×
Current ratio3.1×-1.2×

Where this comes from

Reported directly by Lantheus Holdings in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Lantheus Holdings’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336795
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Other current and noncurrent assets4,844(1,916)
Accounts payable1,5809,365
Accrued expenses and other current and noncurrent liabilities21,015(2,619)
Net cash provided by operating activities217,330194,669
Cash flows from investing activities:
Capital expenditures(5,561)(16,679)
Acquisition of in-process research and development(5,413)
Proceeds from sale of business, net of transaction costs24,212

Item 1. Financial Statements

FAQ

What is Lantheus Holdings's operating cash flow?
Lantheus Holdings (LNTH) reported operating cash flow of $92.2M in Q2 2026.
How has Lantheus Holdings's operating cash flow changed year-over-year?
Lantheus Holdings's operating cash flow increased by 5.9% year-over-year, from $87.11M to $92.2M.
What is the long-term trend for Lantheus Holdings's operating cash flow?
Over 3 years (2021 to 2025), Lantheus Holdings's operating cash flow has grown at a 93.4% compound annual growth rate (CAGR), from $53.92M to $390.14M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Lantheus Holdings's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude